News - BioPharm International

ADVERTISEMENT

News

Pfizer to Acquire Vaccines from Baxter

July 30, 2014

Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.

GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate

July 29, 2014

The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

July 28, 2014

Bristol-Myers Squibb and Ono Pharmaceutical will jointly develop and commercialize immuno-oncology drugs for Japan, South Korea, and Taiwan.

FDA Accepts First Biosimilar Filing

July 24, 2014

Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.

Compounding Pharmacy Issues Recall, But Challenges FDA Decision

July 22, 2014

Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.

AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes

July 21, 2014

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

AbbVie to Acquire Shire for $54.7 Billion

July 18, 2014

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters

July 18, 2014

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

Particulate Matter Prompts Baxter's Recall of IV Solutions

July 17, 2014

Baxter investigates root cause of cellulosic fibers and/or plastics in four lots of IV solutions.

ADVERTISEMENT

ADVERTISEMENT

Click here